TKT and prostate carcinoma: However, the TK 210 ELISA (sensitivity = 44%) showed significantly higher sensitivity compared to the TK1 activity assay (sensitivity = 25%) in differentiation of prostate cancer sera compared to of blood donors (Fig 9C) at a specificity of 98%.